Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 574086, 8 pages
http://dx.doi.org/10.1155/2015/574086
Review Article

Ophthalmic Metastasis of Breast Cancer and Ocular Side Effects from Breast Cancer Treatment and Management: Mini Review

Department of Ophthalmology, “G. Gennimatas” Hospital of Athens, University of Athens, 154 Mesogeion Avenue, 11527 Athens, Greece

Received 8 November 2014; Revised 1 April 2015; Accepted 12 April 2015

Academic Editor: Stephen H. Safe

Copyright © 2015 Ilias Georgalas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. A. Ban and C. V. Godellas, “Epidemiology of breast cancer,” Surgical Oncology Clinics of North America, vol. 23, no. 3, pp. 409–422, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Dogan, F. Andre, and M. Arnedos, “Issues in clinical research for metastatic breast cancer,” Current Opinion in Oncology, vol. 25, no. 6, pp. 625–629, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. S. H. Giordano, A. U. Buzdar, and G. N. Hortobagyi, “Breast cancer in men,” Annals of Internal Medicine, vol. 137, no. 8, pp. 678–687, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. N. C. F. Hodgson, J. H. Button, D. Franceschi, F. L. Moffat, and A. S. Livingstone, “Male breast cancer: is the incidence increasing?” Annals of Surgical Oncology, vol. 11, no. 8, pp. 751–755, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Pant and U. Dutta, “Understanding and management of male breast cancer: a critical review,” Medical Oncology, vol. 25, no. 3, pp. 294–298, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. M. I. Freedman and J. C. Folk, “Metastatic tumors to the eye and orbit. Patient survival and clinical characteristics,” Archives of Ophthalmology, vol. 105, no. 9, pp. 1215–1219, 1987. View at Publisher · View at Google Scholar · View at Scopus
  7. A. P. Ferry and R. L. Font, “Carcinoma metastatic to the eye and orbit: I. A clinicopathologic study of 227 cases,” Archives of Ophthalmology, vol. 92, no. 4, pp. 276–286, 1974. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Weiss, “Analysis of the incidence of intraocular metastasis,” British Journal of Ophthalmology, vol. 77, no. 3, pp. 149–151, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. C. C. Nelson, B. S. Hertzberg, and G. K. Klintworth, “A histopathologic study of 716 unselected eyes in patients with cancer at the time of death,” American Journal of Ophthalmology, vol. 95, no. 6, pp. 788–793, 1983. View at Publisher · View at Google Scholar · View at Scopus
  10. K.-M. Kreusel, T. Wiegel, M. Stange, N. Bornfeld, and M. H. Foerster, “Intraocular metastasis in metastatic female breast cancer. Incidence, risk factors and therapy,” Ophthalmologe, vol. 97, no. 5, pp. 342–346, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Wiegel, K. M. Kreusel, N. Bornfeld et al., “Frequency of asymptomatic choroidal metastasis in patients with disseminated breast cancer: results of a prospective screening programme,” British Journal of Ophthalmology, vol. 82, no. 10, pp. 1159–1161, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Amer, J. Pe'er, I. Chowers, and I. Anteby, “Treatment options in the management of choroidal metastases,” Ophthalmologica, vol. 218, no. 6, pp. 372–377, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. A. P. Ferry, “Metastatic carcinoma of the eye and ocular adnexa,” International Ophthalmology Clinics, vol. 7, no. 3, pp. 615–658, 1967. View at Google Scholar · View at Scopus
  14. G. Olfa, H. Riadh, T. Sameh, B. H. Fafani, and B. A. Slim, “Breast cancer discovered from choroidal metastasis: apropos of a case and review of the literature,” Canadian Journal of Ophthalmology, vol. 44, no. 6, article e67, 2009. View at Publisher · View at Google Scholar
  15. M. Amichetti, O. Caffo, E. Minatel et al., “Ocular metastases from breast carcinoma: a multicentric retrospective study,” Oncology Reports, vol. 7, no. 4, pp. 761–765, 2000. View at Google Scholar · View at Scopus
  16. A. P. Ferry and R. L. Font, “Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases,” Archives of Ophthalmology, vol. 92, no. 4, pp. 276–286, 1974. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Weiss, “Comments on hematogenous metastatic patterns in humans as revealed by autopsy,” Clinical & Experimental Metastasis, vol. 10, no. 3, pp. 191–199, 1992. View at Publisher · View at Google Scholar · View at Scopus
  18. A. McCartney, “Intraocular metastasis,” British Journal of Ophthalmology, vol. 77, no. 3, p. 133, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. Shields and C. L. Shields, “Metastatic tumors to the intraocular structures,” in Intraocular Tumors, J. A. Shields and C. L. Shields, Eds., pp. 207–238, Saunders, Philadelphia, Pa, USA, 1992. View at Google Scholar
  20. H. Demirci, C. L. Shields, A.-N. Chao, and J. A. Shields, “Uveal metastasis from breast cancer in 264 patients,” American Journal of Ophthalmology, vol. 136, no. 2, pp. 264–271, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. G. L. Kanthan, J. Jayamohan, D. Yip, and R. M. Conway, “Management of metastatic carcinoma of the uveal tract: an evidence-based analysis,” Clinical and Experimental Ophthalmology, vol. 35, no. 6, pp. 553–565, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Konstantinidis, I. Rospond-Kubiak, I. Zeolite et al., “Management of patients with uveal metastases at the Liverpool Ocular Oncology Centre,” British Journal of Ophthalmology, vol. 98, no. 1, pp. 92–98, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. R. F. Stephens and J. A. Shields, “Diagnosis and management of cancer metastatic to the uvea: a study of 70 cases,” Ophthalmology, vol. 86, no. 7, pp. 1336–1349, 1979. View at Publisher · View at Google Scholar · View at Scopus
  24. C. L. Shields, J. A. Shields, N. E. Gross, G. P. Schwartz, and S. E. Lally, “Survey of 520 eyes with uveal metastases,” Ophthalmology, vol. 104, no. 8, pp. 1265–1276, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. J. J. Woog, J. Chess, D. M. Albert, D. K. Dueker, F. G. Berson, and J. Craft, “Metastatic carcinoma of the iris simulating iridocyclitis,” British Journal of Ophthalmology, vol. 68, no. 3, pp. 167–173, 1984. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. R. Barishak, E. Baruh, and M. Lazar, “Metastatic tumor of the iris: case report,” Annals of Ophthalmology, vol. 10, no. 9, pp. 1191–1193, 1978. View at Google Scholar · View at Scopus
  27. J. A. Shields, C. L. Shields, H. Kiratli, and P. de Potter, “Metastatic tumors to the iris in 40 patients,” The American Journal of Ophthalmology, vol. 119, no. 4, pp. 422–430, 1995. View at Publisher · View at Google Scholar · View at Scopus
  28. J. A. Shields, C. L. Shields, and A. D. Singh, “Metastatic neoplasms in the optic disc: the 1999 Bjerrum lecture: Part 2,” Archives of Ophthalmology, vol. 118, no. 2, pp. 217–224, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. W. E. Lieb, J. A. Shields, C. L. Shields, and G. L. Spaeth, “Mucinous adenocarcinoma metastatic to the iris, ciliary body, and choroid,” British Journal of Ophthalmology, vol. 74, no. 6, pp. 373–376, 1990. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Weiss, W. Grisold, K. Jellinger, J. Mühlbauer, W. Scheiner, and M. Vesely, “Metastasis of solid tumors in extraocular muscles,” Acta Neuropathologica, vol. 65, no. 2, pp. 168–171, 1984. View at Publisher · View at Google Scholar · View at Scopus
  31. A. van der Heijden, A. Twijnstra, W. P. M. A. Lamers, P. S. G. J. Hupperets, and G. Freling, “An unusual cause of diplopia in a cancer patient,” European Journal of Cancer, vol. 27, no. 10, pp. 1315–1316, 1991. View at Publisher · View at Google Scholar · View at Scopus
  32. J. W. Henderson, Orbital Tumors, WB Saunders, Philadelphia, Pa, USA, 1973.
  33. G. J. Zhang, I. Adachi, D. F. Yin et al., “Eyelid metastasis from breast cancer showing marked response to chemotherapy,” Japanese Journal of Clinical Oncology, vol. 25, no. 1, pp. 10–15, 1995. View at Google Scholar · View at Scopus
  34. J. D. Bullock and B. Yanes, “Ophthalmic manifestations of metastatic breast cancer,” Ophthalmology, vol. 87, no. 10, pp. 961–973, 1980. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Massot-Punyet, J. Almajano, and J. M. Camacho, “Cerebral metastases,” Revista de Neurologia, vol. 31, no. 12, pp. 1242–1247, 2000. View at Google Scholar · View at Scopus
  36. J. Aharon-Peretz and M. Feinsod, “Visual hemineglect as presenting symptom of right parietal tumors,” Harefuah, vol. 126, no. 1, pp. 5–56, 1994. View at Google Scholar · View at Scopus
  37. G. J. Green and S. Lessell, “Acquired cerebral dyschromatopsia,” Archives of Ophthalmology, vol. 95, no. 1, pp. 121–128, 1977. View at Publisher · View at Google Scholar · View at Scopus
  38. A. S. Polans, D. Witkowska, T. L. Haley, D. Amundson, L. Baizer, and G. Adamus, “Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 20, pp. 9176–9180, 1995. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Budde-Steffen, N. E. Anderson, M. K. Rosenblum et al., “An antineuronal autoantibody in paraneoplastic opsoclonus,” Annals of Neurology, vol. 23, no. 5, pp. 528–531, 1988. View at Publisher · View at Google Scholar · View at Scopus
  40. P. W. Wirtz, P. A. E. S. Smitt, J. I. Hoff et al., “Anti-Ri antibody positive opsoclonusmyoclonus in a male patient with breast carcinoma,” Journal of Neurology, vol. 249, no. 12, pp. 1710–1712, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Natesh, K. J. Chin, and P. T. Finger, “Choroidal metastases fundus autofluorescence imaging: correlation to clinical, OCT, and fluorescein angiographic findings,” Ophthalmic Surgery Lasers and Imaging, vol. 41, no. 4, pp. 406–412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. J. A. Smith, E. S. Gragoudas, and E. B. Dreyer, “Uveal metastases,” International Ophthalmology Clinics, vol. 37, no. 4, pp. 183–199, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Solav, R. Bhandari, A. Sowani, and S. Saxena, “Choroidal metastasis from carcinoma of breast detected on F18-FDG PET CT scan: a case report and review of literature,” Indian Journal of Nuclear Medicine, vol. 25, no. 4, pp. 160–163, 2010. View at Google Scholar · View at Scopus
  44. K. Hemminki, M. Bevier, J. Sundquist, and A. Hemminki, “Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries,” International Journal of Cancer, vol. 132, no. 4, pp. 944–950, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Eide and L. Walaas, “Fine-needle aspiration biopsy and other biopsies in suspected intraocular malignant disease: a review,” Acta Ophthalmologica, vol. 87, no. 6, pp. 588–601, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. A. C. Wolff, M. E. H. Hammond, J. N. Schwartz et al., “American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer,” Archives of Pathology and Laboratory Medicine, vol. 131, no. 1, pp. 18–43, 2007. View at Google Scholar · View at Scopus
  47. M. E. H. Hammond, D. F. Hayes, M. Dowsett et al., “American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer,” Journal of Clinical Oncology, vol. 28, no. 16, pp. 2784–2795, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. G. N. Hortobagyi, “Treatment of breast cancer,” The New England Journal of Medicine, vol. 339, no. 14, pp. 974–984, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. C. L. Shields, J. A. Shields, P. De Potter et al., “Plaque radiotherapy for the management of uveal metastasis,” Archives of Ophthalmology, vol. 115, no. 2, pp. 203–209, 1997. View at Publisher · View at Google Scholar · View at Scopus
  50. C. J. Chen, A. N. McCoy, J. Brahmer, and J. T. Handa, “Emerging treatments for choroidal metastases,” Survey of Ophthalmology, vol. 56, no. 6, pp. 511–521, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. C. K. Osborne, “Tamoxifen in the treatment of breast cancer,” New England Journal of Medicine, vol. 339, no. 22, pp. 1609–1618, 1998. View at Publisher · View at Google Scholar · View at Scopus
  52. M. E. Manquez, M. M. Brown, C. L. Shields, and J. A. Shields, “Management of choroidal metastases from breast carcinomas using aromatase inhibitors,” Current Opinion in Ophthalmology, vol. 17, no. 3, pp. 251–256, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. S. G. Nayfield and M. B. Gorin, “Tamoxifen-associated eye disease: a review,” Journal of Clinical Oncology, vol. 14, no. 3, pp. 1018–1026, 1996. View at Google Scholar · View at Scopus
  54. J. Berry, “Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer,” Clinical Therapeutics, vol. 27, no. 11, pp. 1671–1684, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Baum, A. U. Buzdar, J. Cuzick et al., “Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial,” The Lancet, vol. 359, no. 9324, pp. 2131–2139, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Bergh, P.-E. Jönsson, B. Glimelius, P. Nygren, and SBU-group. Swedish Council of Technology Assessment in Health Care, “A systematic overview of chemotherapy effects in breast cancer,” Acta Oncologica, vol. 40, no. 2-3, pp. 253–281, 2001. View at Publisher · View at Google Scholar · View at Scopus
  57. H. D. Weiss, M. D. Walker, and P. H. Wiernik, “Neurotoxicity of commonly used antineoplastic agents: (first of two parts),” The New England Journal of Medicine, vol. 291, no. 2, pp. 75–81, 1974. View at Publisher · View at Google Scholar · View at Scopus
  58. G. Kende, S. R. Sirkin, P. R. M. Thomas, and A. I. Freeman, “Blurring of vision. A previously undescribed complication of cyclophosphamide therapy,” Cancer, vol. 44, no. 1, pp. 69–71, 1979. View at Publisher · View at Google Scholar · View at Scopus
  59. P. S. Imperia, H. M. Lazarus, and J. H. Lass, “Ocular complications of systemic cancer chemotherapy,” Survey of Ophthalmology, vol. 34, no. 3, pp. 209–230, 1989. View at Publisher · View at Google Scholar · View at Scopus
  60. G. Bonadonna, E. Brusamolino, P. Valagussa et al., “Combination chemotherapy as an adjuvant treatment in operable breast cancer,” The New England Journal of Medicine, vol. 294, no. 8, pp. 405–410, 1976. View at Publisher · View at Google Scholar · View at Scopus
  61. A. D. Letson, F. H. Davidorf, and R. A. Bruce Jr., “Chemotherapy for treatment of choroidal metastases from breast carcinoma,” American Journal of Ophthalmology, vol. 93, no. 1, pp. 102–106, 1982. View at Publisher · View at Google Scholar · View at Scopus
  62. C. A. Hudis, “Trastuzumab—mechanism of action and use in clinical practice,” The New England Journal of Medicine, vol. 357, no. 1, pp. 39–51, 2007. View at Publisher · View at Google Scholar · View at Scopus
  63. E. Munzone, F. Nolè, G. Sanna, and A. Goldhirsch, “Response of bilateral choroidal metastases of breast cancer to therapy with trastuzumab,” Breast, vol. 14, no. 5, pp. 380–383, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. Z. W. Wong, S. J. Phillips, and M. J. Ellis, “Dramatic Response of Choroidal Metastases from Breast Cancer to a Combination of Trastuzumab and Vinorelbine,” Breast Journal, vol. 10, no. 1, pp. 54–56, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. J. I. Lim and Z. Petrovich, “Radioactive plaque therapy for metastatic choroidal carcinoma,” Ophthalmology, vol. 107, no. 10, pp. 1927–1931, 2000. View at Publisher · View at Google Scholar · View at Scopus
  66. R. V. Paul Chan and L. H. Young, “Treatment options for metastatic tumors to the choroid,” Seminars in Ophthalmology, vol. 20, no. 4, pp. 207–216, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. S. B. Rudoler, B. W. Corn, C. L. Shields et al., “External beam irradiation for choroid metastases: identification of factors predisposing to long-term sequelae,” International Journal of Radiation Oncology Biology Physics, vol. 38, no. 2, pp. 251–256, 1997. View at Publisher · View at Google Scholar · View at Scopus
  68. T. Wiegel, D. Bottke, K.-M. Kreusel et al., “External beam radiotherapy of choroidal metastases—final results of a prospective study of the German Cancer Society (ARO 95–08),” Radiotherapy and Oncology, vol. 64, no. 1, pp. 13–18, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. E. K. Tsina, A. M. Lane, D. N. Zacks, J. E. Munzenrider, J. M. Collier, and E. S. Gragoudas, “Treatment of metastatic tumors of the choroid with proton beam irradiation,” Ophthalmology, vol. 112, no. 2, pp. 337–343, 2005. View at Publisher · View at Google Scholar · View at Scopus
  70. M. E. Manquez, C. L. Shields, E. C. Karatza, and J. A. Shields, “Regression of choroidal metastases from breast carcinoma using aromatase inhibitors,” British Journal of Ophthalmology, vol. 89, no. 6, pp. 776–777, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. S. Levinger, S. Merin, R. Seigal, and J. Pe'er, “Laser therapy in the management of choroidal breast tumor metastases,” Ophthalmic Surgery and Lasers, vol. 32, no. 4, pp. 294–299, 2001. View at Google Scholar · View at Scopus
  72. H. Kiratli and S. Bilgiç, “Transpupillary thermotherapy in the management of choroidal metastases,” European Journal of Ophthalmology, vol. 14, no. 5, pp. 423–429, 2004. View at Google Scholar
  73. J. C. Yang, L. Haworth, R. M. Sherry et al., “A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer,” The New England Journal of Medicine, vol. 349, no. 5, pp. 427–434, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. V. Fenicia, S. Abdolrahimzadeh, G. Mannino, S. Verrilli, M. Balestrieri, and S. M. Recupero, “Intravitreal bevacizumab in the successful management of choroidal metastases secondary to lung and breast cancer unresponsive to systemic therapy: a case series,” Eye, vol. 28, no. 7, pp. 888–891, 2014. View at Publisher · View at Google Scholar
  75. S. Kaliki, C. L. Shields, S. A. Al-Dahmash, A. Mashayekhi, and J. A. Shields, “Photodynamic therapy for choroidal metastasis in 8 cases,” Ophthalmology, vol. 119, no. 6, pp. 1218–1222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  76. V. Ratanatharathorn, W. E. Powers, J. Grimm et al., “Eye metastasis from carcinoma of the breast: diagnosis, radiation treatment and results,” Cancer Treatment Reviews, vol. 18, no. 4, pp. 261–276, 1991. View at Publisher · View at Google Scholar · View at Scopus